Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Felices

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Cell Reports. Medicine|June 4, 2026
HIV tri-specific killer engagers directly enhance NK cell function and safely expand NK cells in vivoRoss T Cromarty, Julien A Clain, Yvette Soigner, et al.
Cancer Immunology Research|July 15, 2020
Potent Cytolytic Activity and Specific IL15 Delivery in a Second-Generation Trispecific Killer EngagerMartin Felices, Todd R Lenvik, Behiye Kodal, et al.
Frontiers in Immunology|March 13, 2023
A tri-specific killer engager against mesothelin targets NK cells towards lung cancerPhilippa R Kennedy, Daniel A Vallera, Brianna Ettestad, et al.
Blood|February 11, 2012
Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9Michelle K Gleason, Todd R Lenvik, Valarie McCullar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2016
IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced FunctionDaniel A Vallera, Martin Felices, Ron McElmurry, et al.
Translational Oncology|December 23, 2021
Chondroitin sulfate proteoglycan 4, a targetable oncoantigen that promotes ovarian cancer growth, invasion, cisplatin resistance and spheroid formationJianbo Yang, Qianjin Liao, Matthew Price, et al.
Prostate Cancer and Prostatic Diseases|October 26, 2025
HLA class I expression shapes the tumor immune microenvironment and influences prognosis in prostate cancerPornlada Likasitwatanakul, Carissa Besonen, Alexander K Tsai, et al.
Immunity|April 8, 2018
Interleukin-15 Complex Treatment Protects Mice from Cerebral Malaria by Inducing Interleukin-10-Producing Natural Killer CellsKristina S Burrack, Matthew A Huggins, Emily Taras, et al.
Journal for Immunotherapy of Cancer|February 12, 2025
CD56<sup>bright</sup> cytokine-induced memory-like NK cells and NK-cell engagers synergize against non-small cell lung cancer cancer-stem cellsMaria L Guevara Lopez, Ann Gebo, Monica Parodi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 21, 2026
B7-H3 Gene Expression Shapes Prognosis and Therapeutic Opportunities Across Prostate Cancer Patient GroupsAllison Makovec, Ava P Gustafson, Nishant Gandhi, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Cell Reports. Medicine|June 4, 2026
HIV tri-specific killer engagers directly enhance NK cell function and safely expand NK cells in vivoRoss T Cromarty, Julien A Clain, Yvette Soigner, et al.
Cancer Immunology Research|July 15, 2020
Potent Cytolytic Activity and Specific IL15 Delivery in a Second-Generation Trispecific Killer EngagerMartin Felices, Todd R Lenvik, Behiye Kodal, et al.
Frontiers in Immunology|March 13, 2023
A tri-specific killer engager against mesothelin targets NK cells towards lung cancerPhilippa R Kennedy, Daniel A Vallera, Brianna Ettestad, et al.
Blood|February 11, 2012
Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9Michelle K Gleason, Todd R Lenvik, Valarie McCullar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2016
IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced FunctionDaniel A Vallera, Martin Felices, Ron McElmurry, et al.
Translational Oncology|December 23, 2021
Chondroitin sulfate proteoglycan 4, a targetable oncoantigen that promotes ovarian cancer growth, invasion, cisplatin resistance and spheroid formationJianbo Yang, Qianjin Liao, Matthew Price, et al.
Prostate Cancer and Prostatic Diseases|October 26, 2025
HLA class I expression shapes the tumor immune microenvironment and influences prognosis in prostate cancerPornlada Likasitwatanakul, Carissa Besonen, Alexander K Tsai, et al.
Immunity|April 8, 2018
Interleukin-15 Complex Treatment Protects Mice from Cerebral Malaria by Inducing Interleukin-10-Producing Natural Killer CellsKristina S Burrack, Matthew A Huggins, Emily Taras, et al.
Journal for Immunotherapy of Cancer|February 12, 2025
CD56<sup>bright</sup> cytokine-induced memory-like NK cells and NK-cell engagers synergize against non-small cell lung cancer cancer-stem cellsMaria L Guevara Lopez, Ann Gebo, Monica Parodi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 21, 2026
B7-H3 Gene Expression Shapes Prognosis and Therapeutic Opportunities Across Prostate Cancer Patient GroupsAllison Makovec, Ava P Gustafson, Nishant Gandhi, et al.
Pageof 8